FUKOKU MUTUAL LIFE INSURANCE Co Has $462,000 Holdings in CME Group Inc. (NASDAQ:CME)

FUKOKU MUTUAL LIFE INSURANCE Co trimmed its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 46.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,742 shares of the financial services provider's stock after selling 1,500 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co's holdings in CME Group were worth $462,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wayfinding Financial LLC bought a new position in CME Group during the 1st quarter valued at about $25,000. Cornerstone Planning Group LLC boosted its holdings in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares during the period. New Age Alpha Advisors LLC boosted its stake in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares during the last quarter. Golden State Wealth Management LLC grew its stake in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares in the last quarter. Finally, Alpine Bank Wealth Management acquired a new position in CME Group during the first quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CME. Piper Sandler upped their price objective on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Barclays raised their price objective on CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a research report on Thursday. Wall Street Zen upgraded CME Group from a "sell" rating to a "hold" rating in a report on Saturday, July 5th. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research report on Thursday, April 3rd. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of "Hold" and a consensus price target of $260.93.

Insider Buying and Selling at CME Group

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the sale, the director directly owned 3,668 shares in the company, valued at $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Charles P. Carey sold 500 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director owned 4,900 shares in the company, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Down 0.0%

CME stock opened at $275.08 on Friday. The business has a 50 day moving average of $276.58 and a 200 day moving average of $259.23. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $193.25 and a twelve month high of $290.79. The firm has a market cap of $99.13 billion, a PE ratio of 27.67, a price-to-earnings-growth ratio of 4.44 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the business posted $2.50 EPS. On average, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's dividend payout ratio is presently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.